Braidwell Partners Fund
◆ Fund Size
$3.1B
◆ Check Size
◆ Location
United States
◆ Activity
Statusactively investing
◆ Links
◆ Share this fund
◆ Investment Thesis
Focus on the intersection of AI and biopharmaceuticals, backing both AI-enabled medicine companies and those developing platforms and tools for medicine makers. Uses AI to help identify medicines that should exist but don't yet.
◆ About Braidwell
Braidwell is a US-based investment firm that provides flexible capital to companies transforming human health, investing across public and private markets and across all stages of development. Its approach combines investment research, medical science, biostatistics, commercial analysis, financial structuring, data science, AI, and portfolio engineering. [3]
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Team
| Name | Title | Role | Links |
|---|---|---|---|
| Alex Karnal | Chief Investment Officer, Partner, Co-Founder | founder | in |
| Brian Kreiter | Chief Executive Officer, Partner, Co-Founder | founder | in |
| Jonathan Lee | Partner | partner | in |
| Kaila Krum | Partner | partner | in |
| Narendra Nayak | Partner | partner | in |
| Nick Myerberg | Partner, Head of Artificial Intelligence and Technology | partner | in |
| Sommer Chatwin | Partner | partner | in |
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does Braidwell Partners Fund invest in?
Braidwell Partners Fund invests in Biotech, Drug Discovery, Generative AI, Diagnostics and Healthtech Infrastructure at the pre-seed and seed stages.
Which geographies does Braidwell Partners Fund focus on?
Braidwell Partners Fund focuses on global, and is headquartered in United States.
What is Braidwell Partners Fund's typical check size?
Braidwell Partners Fund typically writes checks of $50M to $200M.